Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ST8SIA4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EXOC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LANCL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DUSP5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FHL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NSUN5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAF4B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP35 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTF2IP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VAPA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CPT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SENP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CPD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JAK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RARS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DOCK7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on